Members of the Cide [cell death-inducing DFFA (DNA fragmentation factor-α)-like effector] gene family have been reported to be associated with lipid metabolism. In the present study, we show that Cidea mRNA levels are markedly reduced by fasting and are restored upon refeeding in mouse livers. To elucidate the molecular mechanism, the promoter region of the mouse Cidea gene was analysed and a putative SRE (sterol-regulatory element) was identified. Studies using luciferase reporter constructs together with electrophoretic mobility-shift assays and chromatin immunoprecipitation confirmed the binding of SREBP-1c (SRE-binding protein 1c) to the putative SRE. Furthermore, adenovirus-mediated overexpression of SREBP-1c led to a dramatic increase in Cidea mRNA. In contrast with the induction of Cidea expression by insulin and TO901317 in wild-type mouse hepatocytes, the stimulatory effects were lost in hepatocytes prepared from SREBP-1c-null mice. Adenovirus-mediated overexpression of Cidea in hepatocytes promoted lipid accumulation and triacylglycerol (triglyceride) storage; however, knockdown of Cidea compromised the ability of SREBP-1c to stimulate lipid accumulation. Taken together, these results suggest that SREBP1c directly mediates the effect of insulin on Cidea in hepatocytes and that Cidea, at least in part, mediates SREBP-1c-dependent lipid accumulation.
INTRODUCTION
Insulin controls not only glucose, but also lipid and protein metabolism in mammalian tissues. In Type 2 diabetes and obesity, hyperinsulinaemia is associated with elevated hepatic synthesis of fatty acids and triacylglycerols (triglycerides) [1] . Critical enzymes involved in lipogenesis, such as FAS (fatty acid synthase), ACC (acetyl-CoA carboxylase) and SCD-1 (sterolCoA desaturase 1), are insulin targets and are regulated by SREBP-1c [SRE (sterol-regulatory element)-binding protein-1c] [2] [3] [4] [5] . SREBP-1c has been identified as an important transcription factor in insulin-mediated lipogenesis signalling in liver, adipose tissue and muscle [3, [6] [7] [8] . Chen et al. [7] demonstrated that the LXR (liver X receptor)-RXR (retinoid X receptor) heterodimer mediates the insulin-induced transcriptional activation of SREBP1c. Studies of TO901317, a highly selective LXR agonist, have shown that it can strongly stimulate SREBP-1c expression in mouse livers and can increase lipogenesis [9, 10] . SREBP-1c abundance is closely related to the nutritional state of the liver and adipose tissue [2, 11, 12] .
SREBP-1c belongs to the SREBP family, which is composed of three members, SREBP-1a, SREBP-1c and SREBP-2. SREBP1a and SREBP-1c are produced from a single gene through the use of alternate promoters and different first exons, whereas SREBP-2 is produced from a separate gene [13, 14] . SREBP-1c is synthesized as a 125 kDa precursor, which, in the presence of sterol, is bound to the endoplasmic reticulum membrane along with SCAP (SREBP-cleavage-activating protein). Upon activation, the SREBP-1c and SCAP complex cluster into COPII (coatamer protein II) vesicles and translocate to the Golgi, where SREBPs are processed into their mature forms [15, 16] . The mature SREBP-1c enters the nucleus to activate numerous target genes.
Studies on lipid metabolism have shed light on a new family of proteins, the Cide (cell death-inducing DFFA-like effector) family, composed of three members, Cidea, Cideb and Cidec/FSP27 (fat-specific protein 27). Of these three members, Cidea is highly expressed in human WAT (white adipose tissue) [17] . A V115F polymorphism in the human CIDEA gene has been shown to be associated with obesity [18] . Furthermore, CIDEA mRNA levels are significantly increased in human adipose tissue and the lipolytic rate in WAT is reduced by 40 % following weight loss [19, 20] . Cidea is also reported to be highly expressed in mouse BAT (brown adipose tissue) [17, 21] . A study on Cideanull mice showed that these mice exhibit a lean phenotype, increased lipolysis, a heightened metabolic rate and increased thermogenesis, and that they are resistant to high-fat-diet-induced obesity and diabetes, which suggests that Cidea plays an important role in the regulation of energy homoeostasis [21] . Ectopic overexpression of Cidea in preadipocytes greatly enhances lipid droplet size and regulates triacylglycerol deposition [19] . Interestingly, increased Cidea expression is observed in Type 2 diabetic mouse livers, and the elevated Cidea expression could be reversed by weight loss and normalization of plasma insulin [22] . Cidea is expressed at low levels in normal mouse livers. However, its expression is markedly up-regulated in ob/ob mouse livers [23] . A further study demonstrated that Cidea is activated by PPARα (peroxisome-proliferator-activated receptor α) and PPARγ ligands, and by PPARα and PPARγ overexpression [24] . The above studies have demonstrated that Cidea is a critical factor involved in lipid metabolism. However, the exact function of Cidea and the link between insulin and Cidea are still not clear.
In the present study, we investigated the association between insulin, SREBP-1c and Cidea expression. Our data show that the induction of Cidea gene expression by insulin and TO901317 is mediated through SREBP-1c, and that Cidea, at least in part, mediates the SREBP-1c-dependent stimulation of lipid accumulation in hepatocytes.
MATERIALS AND METHODS

Mouse treatments
C57BL/6 mice (male, 8 weeks old) were purchased from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College. Mice were kept in a 12 h light/12 h dark cycle and fed a normal chow diet. The mice were anaesthetized with an intraperitoneal injection of bromethol. Livers were perfused with PBS in order to remove blood cells before collection. The mouse protocol was approved by the Animal Research Committee at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College. For the fasting and refeeding experiments, three male mice were included in each treatment group. In the fasting groups, mice were fasted for 48 h before being killed. In the refeeding groups, mice fed a normal chow diet were fasted for 48 h and then were refed a high-carbohydrate/lowfat diet for 12, 24 or 48 h before being killed. Livers were collected and immediately used for nuclear protein preparation and ChIP (chromatin immunoprecipitation) assays. Part of the tissue was frozen in liquid nitrogen for mRNA quantification.
Plasmid construction and recombinant adenovirus preparation
The 3 kb mouse Cidea promoter plasmid pL-Cid1 was a gift from Dr Janardan K. Reddy (Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, U.S.A.) [24] . Different deletion fragments were generated by PCR using pL-Cid1 as the template and then cloned into the NheI/HindIII site of the pGL3-basic vector. The primers used were the following: Cidea promoter + 98 bp, 5 -CCCAAGCTTTCCC-TGGCGGTCTCCATTGG-3 (reverse); − 532 bp, 5 -CTAGCTA-GCACTAGCAACTCCTAATTCCA-3 (forward); − 250 bp, 5 -CTAGCTAGCACGCGTGTCCCCAGCAACTT-3 (forward); and − 100 bp, 5 -CTAGCTAGCCACGCACACCTGCTTCTCTA-3 (forward). The putative SREBP-binding site was mutated by PCR. The primers used were the following: 5 -ATACATCAGCAAGCGGAGTGTCCTAACAGGC-3 (reverse); and 5 -TGCTGATGTATCACCTGCTTCTCTACTGCCAAGCC-AT-3 (forward). Mouse Cidea cDNA was cloned by PCR amplification from mouse liver cDNA and inserted into the Adtrack vector. pcDNA3.1-hSREBP-1a and pcDNA-hSREBP-1c, containing cDNAs encoding the active amino terminal fragments of human SREBP-1a (amino acids 1-460) and human SREBP-1c (amino acids 1-436), were provided by Professor Hitoshi Shimano (Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan) [25] . HA (haemagglutinin) and FLAG tags were added to the C-termini of mature SREBP-1a and SREBP-1c respectively by PCR. All clones were verified by sequencing. Recombinant adenoviruses containing Cidea, mature SREBP-1a and SREBP-1c cDNAs were generated as previously described [26] .
Preparation of primary hepatocytes
SREBP-1c
−/− or SREBP-1c +/+ mice (3 months old, male, C57BL/6J; 129S6/SvEv mixed background) [27] were kept in a 12 h light/12 h dark cycle and fed a normal chow diet. For hepatocyte preparation, mice were anaesthetized with an intraperitoneal injection of bromethol. Livers were subjected to two-step collagenase perfusion through the portal vein as previously described [28] . First, 50 ml of Ca 2+ -free/Mg 2+ -free HBSS (Hanks balanced salt solution) supplemented with 2 mM EGTA, 20 mM Hepes and 10 mM NaHCO 3 , pH 7.4, was infused with a pump at a flow rate of 7 ml/min for 6 min. Then the livers were perfused with HBSS containing 0.05 % (w/v) collagenase type I (Sigma) at the same flow rate for 5 min. The HBSS was pre-infused with 95 % O 2 and 5 % CO 2 and kept in a 37
• C water bath. After the two-step perfusion, livers were excised and hepatocytes were flushed out and filtered through a 250 μm pore size mesh nylon filter. Cells were washed three times with ice-cold HBSS and centrifuged at 50 g for 2 min at 4
• C. The cells were more than 80 % viable, as evaluated by Trypan Blue exclusion. Hepatocytes were seeded at 10 7 cells/10 cm 2 on rat tail collagencoated plates and cultured with RPMI 1640 medium (H10394; Invitrogen) containing 10 % (v/v) FBS (fetal bovine serum), 2.5 nM insulin, 1 nM dexamethasone, 50 units/ml penicillin and 50 μg/ml streptomycin. After 2 h, unattached cells were washed away with PBS and fresh medium was added for an overnight incubation.
Transient transfection and luciferase assays
HepG2 cells were grown in high-glucose DMEM (Dulbecco's modified Eagle's medium) (H10391; Invitrogen) containing 10 % (v/v) FBS in 24-well plates. When the cells reached 80 % confluency, they were co-transfected with Cidea promoter plasmids and pcDNA3.1-hSREBP-1a, pcDNA3.1-hSREBP-1c or with the vehicle pcDNA3.1 plasmid using Lipofectamine TM 2000 (11668027; Invitrogen). A Renilla luciferase expression vector, pCMV-RL-TK, was used as an internal control to adjust for transfection efficiency. Luciferase activity was measured 48 h later with the Dual Luciferase Reporter Assay System (E1980; Promega).
Cell culture and treatment
Mouse primary hepatocytes were kept in RPMI 1640 medium containing 10 % (v/v) FBS, 50 units/ml of penicillin and 50 μg/ml of streptomycin. For adenovirus infection, the cells were infected at a multiplicity of infection sufficient to infect >95 % of the cells, as determined by GFP (green fluorescent protein) fluorescence. The final concentrations of insulin and TO901317 used to treat the cells were 80 nM and 5 μM respectively. Cells were harvested 48 h after treatment for quantitative real-time PCR and Western blot analysis.
EMSA (electrophoretic mobility-shift assay)
The plasmids pCMV6-XL5-hSREBP-1a/HA or pCMV6-XL5-hSREBP-1c/FLAG were used to transfect HEK (human embryonic kidney)-293A cells. Nuclear extracts were prepared using the NE-PER Nuclear and Cytoplasmic extraction reagent (78833; Pierce). The EMSA experiment was performed using the Chemiluminescent Nucleic Acid Detection Module kit (89880; Pierce). Synthetic oligomers were prepared commercially by Invitrogen Biotechnology. The biotinlabelled oligonucleotide containing the Cidea promoter SRE was: 5 -TTAGGACACTCCGCTCGCCCCACGCACACCTGC-TTCTCTACTGCCAAGCC-3 and the SRE-mutated oligonucleotide was: 5 -TTAGGACACTCCGCTAGATGATGGCAC-ACCTGCTTCTCTACTGCCAAGCC-3 . These oligonucleotides annealed with their respective reverse complementary sequences to form double-stranded oligonucleotides.
ChIP assays
Mouse livers were homogenized and treated for 10 min with 1 % (v/v) formaldehyde at room temperature (25
• C). The crosslinking reaction was stopped by the addition of glycine at a final concentration of 125 mM. Chromatin was extracted and fragmented further to an average length of 500 bp by sonication. After pre-clearing with Protein G beads, the chromatin was immunoprecipitated with antibodies against SREBP-1 or FoxA2 (forkhead box A2) (sc-13551; Santa Cruz Biotechnology and 07-633; Millipore), or with a control IgG at 4
• C overnight. Then antibody-protein-DNA complexes were isolated by immunoprecipitation with Protein G beads. After extensive washing, the complexes were eluted and incubated in a 65
• C water bath to reverse the formaldehyde cross-links. DNA was extracted by phenol/chloroform/isoamyl alcohol (25:24:1) and precipitated with ethanol. Samples were analysed by PCR. The primers were designed to amplify a region of the mouse Cidea gene promoter that contains the SREBP-1-binding site. The forward and reverse primers used were 5 -CTTTGGAGACTCCAGCATGC-3 and 5 -TCTCTTCTGGAGACTGGGGT-3 respectively. The CYP3A11 promoter was used as a positive control for the FoxA2 antibody [29] .
RNA extraction, reverse transcription and real-time PCR
Total RNA was extracted from mouse livers and mouse primary hepatocytes using the Invitrogen TRIzol ® reagent and reverse transcribed into cDNA using Invitrogen SuperScript ® III Reverse Transcriptase. Quantitative real-time PCR was performed using the SYBR Green I Q-PCR kit (Transgen) using the above cDNA as the template. A melting curve analysis was performed after the PCR. Primers used for the real-time PCR were the following: mouse β-actin, 5 -CCAGCCTTCCTTCTTGGG-TAT-3 (forward) and 5 -TGCTGGAAGGTGGACAGTGAG-3 (reverse); mouse Cidea, 5 -TCCTCGGCTGTCTCAATG-3 (forward) and 5 -TGGCTGCTCTTCTGTATCG-3 (reverse); mouse SREBP-1c, 5 -CTTCTGGAGACATCGCAAAC-3 (forward) and 5 -GGTAGACAACAGCCGCATC-3 (reverse); mouse FAS, 5 -CTTGGGTGCTGACTACAACC-3 (forward) and 5 -GCCCTCCCGTACACTCACTC-3 (reverse); mouse ACC-1, 5 -AGGAAGATGGCGTCCGCTCTG-3 (forward) and 5 -GGTGAGATGTGCTGGGTCAT-3 (reverse); and mouse SCD-1, 5 -TGGGTTGGCTGCTTGTG-3 (forward) and 5 -GC-GTGGGCAGGATGAAG-3 (reverse).
Western blot analysis
Cell lysates were centrifuged at 12 000 g at 4
• C for 15 min, and the supernatants were kept for Western blot analysis. Protein concentrations were determined using the Pierce BCA (bicinchoninic acid) kit. Equal amounts of protein were separated by SDS/PAGE (10 % gel) and transferred onto 0.22 μM PVDF membranes (Millipore) after electrophoresis. Blots were probed with primary antibodies at 4
• C overnight. 
RNA interference and lipid droplet analysis
Short hairpin RNA-coding DNAs were synthesized by Invitrogen and inserted into adenovirus plasmids. Adenoviruses were prepared according to previously described procedures [26, 31] . siRNAs (small interfering RNAs) transcribed from the above adenoviruses included the following: scrambled siRNA, 5 -CUUACGCUGAGUACUUCGA-3 ; siCidea1, 5 -GGA-CACCGGGUAGUAAGUA-3 [19] ; and siCidea2, 5 -AGAUGU-ACUCCGUGUCCUA-3 . Mouse primary hepatocytes were infected with Ad-GFP, Ad-SREBP-1c, Ad-Cidea, Adscrambled siRNA (control), Ad-siCidea1 and Ad-siCidea2. Gene knockdown efficiency was examined by real-time PCR. For Oil Red O staining, cells were fixed with paraformaldehyde first and then stained with Oil Red O. After three washes, the cells were viewed under a microscope.
Hepatocyte triacylglycerol content
Primary hepatocytes were washed three times with PBS before the cells were disrupted with cell lysis buffer (20 mM Tris/HCl, pH 7.4, 1 mM EDTA and 1 % Triton X-100). After being centrifuged at 12 000 g for 10 min, supernatants were collected for an enzymatic assay using a triacylglycerol assay kit (Sigma).
Statistical analysis
Quantitative data are represented as the means + − S.E.M. For statistical analysis, the differences between groups were examined using a paired Student's t test, and P 0.05 was considered statistically significant.
RESULTS
Cidea gene expression in mouse livers decreased during fasting and was restored upon refeeding mRNA was extracted from mouse livers and quantified by realtime PCR. Fasting led to a decrease in the mRNA levels of SREBP1c, Cidea, FAS and ACC-1 compared with the mRNA levels in mice fed with normal diet (Figure 1) , and refeeding caused these levels to increase from the fasting levels. The regulatory trends of SREBP-1c, ACC-1 and FAS under fasting-refeeding conditions were consistent with previous reports [12, 32] . Cidea showed an expression pattern that was similar to those of FAS and ACC-1 under these conditions. Our Western blot analysis result showed that fasting led to a decrease in nuclear SREBP-1c protein levels and refeeding restored SREBP-1c expression in mice liver ( Figure 1E ). Previous studies have demonstrated that SREBP-1c is the major mediator of insulin's effect on FAS and other lipogenic genes in adipose tissue and in the liver [32] . Thus we speculated that SREBP-1c may also regulate Cidea gene expression.
SREBP-1c stimulated the transcription of Cidea by directly binding to the SRE identified in the Cidea gene promoter
We first searched for a sequence motif in the mouse Cidea gene promoter region. A screen of the sequence from − 600 bp to + 98 bp relative to the transcription start site revealed a putative SRE located from − 134 bp to − 126 bp (Figure 2A) . A series of luciferase reporter constructs under the control of different deletion fragments of the Cidea promoter was prepared and transfected into HepG2 cells together with SREBP-1 expression plasmids or the vehicle pcDNA3.1 plasmid. Dual-luciferase reporter assay results showed that the overexpression of both SREBP-1a and SREBP-1c led to the considerable activation of the reporter gene containing the − 532/+ 98 bp region of the Cidea promoter ( Figure 2B ). This activation remained when the promoter region was truncated to − 250/+ 98 bp, which still contained the putative SREBP-1-binding site. However, when the reporter gene was further truncated to − 100/+ 98 bp (completely deleting the putative SRE), the activation was almost completely lost. To further confirm that this SRE was functional, mutation studies were performed. When the putative SRE element (− 134 bp to − 126 bp) was mutated, the activation of the Cidea gene promoter by SREBP-1 was lost ( Figure 2B ), suggesting that the SRE (− 134/− 126 bp) identified in the Cidea promoter was a functional SREBP-1 cis-element. (B) HepG2 cells were co-transfected with plasmids harbouring a 5 -deletion series of the Cidea promoter fused to a luciferase reporter (including the wild-type Cidea gene promoter sequence and its mutant) and SREBP-1 protein expression plasmids or pcDNA3.1 (control). Cells were lysed 48 h after transfection and luciferase activity was measured as described in the Materials and methods section. The graph depicts relative luciferase activity (RLA) corrected for Renilla luciferase activity and normalized to the control activity of Cidea (transfected with pcDNA3.1). All values represent at least three independent transfections, each conducted in triplicate. *P 0.05 compared with control group (transfected with pcDNA3.1).
To determine whether SREBP-1 proteins were physically bound to the Cidea SRE, an EMSA was performed using nuclear extracts and the synthetic double-stranded oligonucleotides. ChIP assays were performed using fasted and refed mouse livers. After cross-linking, the nuclei were isolated and sonicated, and protein-DNA complexes were immunoprecipitated with anti-SREBP-1, anti-FoxA2 (negative control) or normal IgG antibodies (negative control). The resultant DNA was analysed by PCR with primers amplifying the promoter region flanking Cidea SRE. FoxA2 can specifically bind to the CYP3A11 gene promoter (positive control), which is consistent with a previous study [29] .
As shown in Figure 3 (A), the nuclear proteins extracted from HEK-293A cells overexpressing SREBP-1a-HA and SREBP1c-FLAG reacted with the labelled oligonucleotide probes and formed shifted bands. The addition of a 200-fold excess of an unlabelled Cidea SRE competitor abolished the formation of the protein-DNA complex, leading to the disappearance of the band-shift. In sharp contrast, the addition of a 200-fold excess of the mutant unlabelled competitor did not affect the formation of this complex. When HA and FLAG antibodies were added to the reaction system individually, super-shift bands were observed. A well-defined SRE element (AIICD) in the human APOAII (apolipoprotein AII) promoter [33] was used as a positive control ( Figure 3A) . Taken together, these results indicate that SREBP-1 is specifically involved in this interaction and that SREBP-1 is physically bound to Cidea SRE in vitro.
In addition, ChIP assays were carried out with mouse livers to investigate whether SREBP-1 can be recruited to the Cidea promoter in vivo. Primers were designed to amplify a fragment flanking the SRE region of the Cidea gene promoter. Mice were fasted and refed for 48 h before being killed in order to decrease and then restore liver SREBP-1c protein levels. Liver chromatin was precipitated with an anti-SREBP-1 antibody or with an antiFoxA2 antibody as a negative control. As expected, SREBP-1 occupied the promoter of the Cidea gene under the normal diet condition, and this binding was almost undetectable during fasting. However, occupancy of SREBP-1 at the Cidea gene promoter was restored in the livers after refeeding ( Figure 3B ). In addition, FoxA2 did not bind to the SRE region of the Cidea gene promoter, although it did occupy the CYP3A11 promoter ( Figure 3B ), which is a well-defined FoxA2 downstream target gene [29] .
Adenovirus-mediated overexpression of mature SREBP-1 stimulates Cidea expression
Because the SREBP-1 proteins activate the mouse Cidea promoter by directly binding to the Cidea SRE element, we reasoned that the SREBP-1 proteins could affect Cidea at the mRNA level. We used mouse primary hepatocytes as a model system. Hepatocytes were infected with adenoviruses expressing mature SREBP-1a, SREBP-1c or GFP as a negative control. Western blotting results indicated that the adenoviruses effectively mediated the expression of the mature active SREBP-1 proteins ( Figure 4D ). Total RNA was extracted from these cells and the levels were quantified by real-time PCR. As expected, overexpression of mature SREBP-1a and SREBP-1c led to a dramatic induction of Cidea, FAS and SCD-1 ( Figures 4A-4C) . Additionally, overexpressing SREBP-1c also increases Cidea mRNA levels in 3T3-L1 and C2C12 cells (results not shown).
Insulin and TO901317 induced Cidea expression via SREBP-1c
In order to study further whether SREBP-1c mediates the effect of insulin on Cidea gene expression, hepatocytes prepared from SREBP-1c-null mice were used. The SREBP-1c-null mice exhibit lower total plasma triacylglycerols and a reduction in multiple mRNAs encoding enzymes for fatty acid synthesis, such as FAS and ACC. In this model system, the first exon of the SREBP-1c gene is deleted, thus SREBP-1c transcription is abolished, whereas the SREBP-1a transcript is left intact [27] . Primary hepatocytes prepared from wild-type mouse livers (wild-type hepatocytes) as well as SREBP-1c-null mouse livers (knockout hepatocytes) were treated with insulin or TO901317 for 48 h. As shown in Figure 5 (A), in the wild-type hepatocytes, SREBP1c mRNA increased by approx. 4.6-fold upon insulin treatment, compared with the control group, which is consistent with previous studies [2, 34] . In accordance, an approx. 4.5-fold increase in the mRNA levels of Cidea was observed in hepatocytes following insulin and TO901317 treatment. Our Western blot results indicate that the protein levels of mature SREBP-1c and Cidea were also markedly increased in the presence of insulin and TO901317 ( Figure 5B ). In addition, adenovirus-mediated overexpression of SREBP-1c also caused a dramatic increase in Cidea protein levels. SREBP-1c is the dominant form of SREBP family proteins in the liver and is selectively stimulated by insulin in the lipid metabolism pathway [6, [34] [35] [36] . Because both Cidea and SREBP-1c gene expression are induced by insulin and TO901317, and SREBP-1c stimulates Cidea at both the mRNA and protein levels, it is reasonable to hypothesize that SREBP-1c mediates the activity of insulin and TO901317 on Cidea gene expression. Our results confirmed this notion ( Figures 5C and  5D ). Insulin and TO901317 cannot stimulate Cidea at either the mRNA level or protein level in primary hepatocytes prepared from SREBP-1c-null mice, which is in sharp contrast with what was observed in wild-type mouse hepatocytes. In addition, adenovirus-mediated restoration of SREBP-1c in the SREBP-1c-null mouse hepatocytes led to an increase in Cidea expression ( Figure 5D ). Taken together, these results strongly suggest that insulin and TO901317 stimulate Cidea gene expression in an SREBP-1c-dependent manner.
Cidea increases lipid droplet size and partially mediates SREBP-1c stimulation of lipid accumulation in hepatocytes
To study the physiological role of the SREBP-1c-dependent activation of Cidea, adenoviruses expressing siRNA targeting Cidea were constructed. The siRNA were effectively expressed under the control of a H1 RNA promoter. Two efficient siRNA sequences for silencing Cidea expression were selected from several candidates. Our results indicate that Cidea mRNA was decreased by siCidea1 and siCidea2, compared with the scrambled siRNA control group ( Figure 6A) .
We examined whether Cidea could affect lipid droplet formation and triacylglycerol content in mouse hepatocytes. As shown in Figures 6(B) and 6(C), adenovirus-mediated overexpression of Cidea in mouse hepatocytes led to lipid droplet enlargement and stimulated triacylglycerol storage. Cidea has been previously reported to stimulate lipid accumulation in adipocytes [19] , and these results suggest that Cidea has the same affect in hepatocytes. A previous study demonstrates that the overexpression of mature SREBP-1c in hepatocytes induces lipid accumulation [8] . Our result confirmed this report ( Figures 6B  and 6C ). However, when hepatocytes were co-infected with Ad-SREBP-1c and Ad-siCidea1/2, the specific knockdown of Cidea by siRNA suppressed the ability of SREBP-1c to stimulate lipid accumulation ( Figures 6B and 6C) , suggesting that Cidea is a direct mediator of SREBP-1c-dependent lipid accumulation in hepatocytes.
DISCUSSION
It is well established that the activity of insulin on fatty acid synthesis in the liver is mediated by SREBP-1c [13] . Our present study on the livers of mice that were fasted and refed revealed that Cidea mRNA fluctuates in response to dietary changes. The amount of liver Cidea mRNA declined dramatically in response to fasting and increased gradually upon refeeding. Cidea showed a similar expression pattern as SREBP-1c downstream genes under fasting and refeeding conditions [12] . This implies that Cidea expression may be regulated by SREBP-1c, and that SREBP-1c may mediate the effects of insulin on Cidea expression following a fasting-refeeding treatment.
The main goal of the present study was to elucidate the molecular mechanism of insulin-mediated Cidea stimulation. A screen of the mouse Cidea promoter region revealed the presence of several putative transcription-factor-binding sites, including SRE-, GATA-, HNF4 (hepatocyte nuclear factor 4)-and PPRE (PPARresponsive element)-binding sites, the last of which has been shown to be functional for PPARα and PPARγ ligands [19, 24] . However, no LXRE (LXR-response element) was found. Because both insulin and TO901317 induce SREBP-1c gene expression in hepatocytes [34, 37] , and a potential SRE was identified in the mouse Cidea promoter region, we speculated that this SRE may be functional. Indeed, the present studies using EMSA and ChIP assays demonstrate that the SRE element, which is located between base pairs − 134 and − 126 from the transcription initiation site of Cidea, directly interacts with SREBP-1a and SREBP-1c both in vitro and in vivo. Our mutation studies using luciferase reporter constructs confirmed this conclusion.
In the liver, LXR mediates insulin's induction of SREBP-1c expression [7] . The resultant SREBP-1c is a general mediator of insulin's effects. Our results from the present study indicate that the reduction in Cidea mRNA in the livers of fasting mice (low plasma insulin levels) can be gradually restored after refeeding with a high-carbohydrate/low-fat diet (high plasma insulin levels). Moreover, overexpression of SREBP-1c leads to a dramatic increase in Cidea mRNA and protein in mouse hepatocytes. These results from the present study, in combination with a previous study [7] , imply that the effect of insulin on Cidea expression may occur through a SREBP-1c-dependent pathway. Further studies using primary hepatocytes prepared from SREBP-1c-knockout mouse livers confirm this suggestion. The present study shows that neither insulin nor TO901317 has a stimulatory effect on Cidea in SREBP-null hepatocytes. In liver, SREBP-1c is the predominant isoform of SREBP-1 (SREBP-1c mRNA is 9-fold more abundant than SREBP-1a) [35] . Although overexpression of SREBP-1a can also stimulate Cidea, it is not likely that SREBP-1a mediates the effect of insulin on Cidea since insulin fails to induce the expression of Cidea in hepatocytes isolated from the SREBP-1c-null mouse liver, even though expression of SREBP-1a remains intact [27] . These results strongly indicate that SREBP-1c, but not SREBP-1a or other transcription factors, mediates the effects of insulin on Cidea gene expression.
Previous reports suggest that overexpression of SREBP-1c in the liver leads to a considerable increase in lipid synthesis [8, 38] , and our studies indicate that Cidea is a direct target of SREBP1c. Thus we speculated that Cidea may mediate the effect of SREBP-1c on lipid accumulation. We demonstrate that the overexpression of Cidea in hepatocytes promotes lipid accumulation. Similar results were also observed in adipocytes [19] . However, it is noteworthy that Cidea has a much smaller effect on lipid droplets than SREBP-1c does. Furthermore, a knockdown of Cidea expression by adenovirus-mediated siRNA suppressed the SREBP-1c-mediated stimulation of lipid accumulation in hepatocytes. This suggests that Cidea, at least in part, mediates the effect of SREBP-1c on lipid accumulation. However, we have to point out that knockdown of Cidea was not performed in hepatocytes treated with insulin or TO901317 since insulin or TO901317 compound alone can not powerfully stimulate lipogenesis in hepatocytes as overexpression of SREBP1c mediated by adenovirus does, which was evaluated with Oil Red O staining (results not shown).
Cidea and Cidec are both reported to be lipid droplet proteins [19, 39] and these two proteins are both elevated in ob/ob mouse steatotic liver [22, 23] . One study suggests that Cidec overexpression in hepatocytes causes a greater stimulation of lipid accumulation than Cidea does [23] . However, we found that Cidec is only modestly induced in primary hepatocytes by SREBP-1c as compared with Cidea (results not shown).
In summary, the results of the present study indicates that changes in Cidea expression follow the fluctuations of SREBP-1c in the livers of fasted and refed mice. SREBP-1c significantly stimulates Cidea at both the mRNA and protein levels in primary hepatocytes. In the liver, SREBP-1c mediates the induction of Cidea gene expression by insulin and an LXR agonist. Furthermore, overexpression of Cidea in hepatocytes promotes lipid droplet formation, whereas knockdown of Cidea expression partially suppresses the SREBP-1c-mediated effect on lipid accumulation.
In obese rodents and humans, the up-regulation of SREBP-1c expression may result in excesive lipogenesis and insulin resistance, further causing liver steatosis [40] [41] [42] [43] . Given the dramatic induction of Cidea by SREBP-1c and its specific expression pattern in ob/ob mice [23] , Cidea may participate in the SREBP-1c-dependent liver steatosis pathway. Hyperinsulinaemia is often associated with hyperlipidaemia in livers through the induction of lipogenesis-related genes. In obese and Type 2 diabetic subjects, hyperinsulinaemia may result in elevated SREBP-1c levels in the liver [33, 41] , which in turn up-regulates Cidea gene expression, causing lipid droplet accumulation in hepatocytes and the development of liver steatosis. Further studies are needed to elucidate the exact function of Cidea in lipid metabolism in order to fully understand the pathology of liver steatosis in insulin resistance and obesity.
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